𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SIAH1 inactivation correlates with tumor progression in hepatocellular carcinomas

✍ Scribed by Koichi Matsuo; Seiji Satoh; Hiroshi Okabe; Akinari Nomura; Toshiki Maeda; Yoshio Yamaoka; Iwao Ikai


Book ID
102218230
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
465 KB
Volume
36
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Accumulation of loss of heterozygosity (LOH) on chromosome 16 is frequently observed in human hepatocellular carcinomas (HCCs). To identify tumor‐suppressor genes (TSGs) involved in hepatocarcinogenesis, we performed deletion mapping of chromosome 16 in 59 HCCs. Three commonly deleted regions, located in 16q12.1, 16q22.1, and 16q24.2, were observed. Because there has been no study on LOH at locus 16q12.1 in HCCs, we focused on this region. By searching the Human Genome Database at the National Center for Biotechnology Information web site, we identified 14 known genes in 16q12.1 as TSG candidates. Among these, the expression of SIAH1 was markedly downregulated in HCCs, and inactivation of SIAH1 expression was associated with LOH at 16q12.1. A mutation analysis of SIAH1 revealed no somatic mutations, but one single nucleotide polymorphism was found among the 35 HCCs investigated. Subsequently, we evaluated the relation between SIAH1 expression, confirmed by semiquantitative RT‐PCR, and clinicopathological parameters in HCCs. SIAH1 was significantly downregulated in advanced HCCs, including poorly differentiated tumors, larger tumors, and tumors in advanced stages. These findings suggest that inactivation of SIAH1 plays an important role in HCC progression. Β© 2003 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Promoter hypermethylation of fibulin 1 g
✍ Mitsuro Kanda; Shuji Nomoto; Yukiyasu Okamura; Masamichi Hayashi; Mitsuhiro Hish πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 430 KB

## Abstract Hepatocellular carcinoma (HCC) is one of the most common cancers world‐wide but the molecular mechanisms that underlie hepatocarcinogenesis are not fully determined. On the same surgical sample with HCC, we performed microarray‐based gene expression profiling and karyotype analysis usin